Bristol-Myers Squibb (BMY) Declares $0.37 Quarterly Dividend; 2.4% Yield

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Bristol-Myers Squibb (BMY) Declares $0.37 Quarterly Dividend; 2.4% Yield

Bristol-Myers Squibb Announces Dividend

September 17, 2015 4:32 PM EDT

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers... More

Bristol-Myers Squibb’s Opdivo (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Advanced Renal Cell Carcinoma

September 16, 2015 8:01 AM EDT

Designation based on positive results of the Phase 3 study, CheckMate -025, reinforcing significant unmet medical need in this patient population

CheckMate -025 marks the first time any agent has demonstrated, as a primary endpoint, an overall survival benefit vs. standard of care in second-line metastatic renal cell carcinoma

PRINCETON, N.J.--(BUSINESS WIRE)--... More